By Action RCM Powered by Harris & Harris
In the modern healthcare ecosystem, denials have quietly become one of the most expensive leak points in hospital revenue. On average, 10–15% of all claims are denied at least once, with up to 65% of those denials never resubmitted. For a 300-bed hospital, that can translate into tens of millions of dollars in delayed or lost reimbursement annually.
Amid labor shortages, tightening margins, and rising payer complexity, one question has taken center stage: Who should manage denials in today’s revenue cycle; artificial intelligence or human experts? The truth is that neither can succeed alone. The most forward-thinking health systems are embracing a hybrid model where automation drives efficiency and human intelligence ensures accuracy, compliance, and payer-specific strategy.
The Promise of AI in Denials Management
Artificial intelligence (AI) and machine learning (ML) have evolved from buzzwords to operational necessities in revenue cycle management (RCM). Today’s denial-management tools can automatically read remittance files, categorize CARC/RARC codes, predict denial likelihood, and even generate first-level appeal letters.
Key capabilities driving AI’s adoption include:
- Predictive Analytics: Machine learning models analyze historical claim data to identify patterns that indicate which claims are most at risk for denial which allows teams to intervene before submission.
- Intelligent Work Queues: AI can prioritize denials by financial impact, payer, and probability of overturn, ensuring staff focus on the most recoverable dollars.
- Automation of Routine Tasks: From eligibility verification to authorization validation and charge correction, automation reduces manual rework and accelerates resubmission.
- Root Cause Analysis: Advanced platforms aggregate denial data across payers, highlighting systemic trends such as documentation gaps or coding inconsistencies that drive recurring issues.
When deployed effectively, AI can cut denial turnaround times by 30–50%, improve first-pass clean-claim rates, and reduce reliance on expensive manual labor. For CFOs, the ROI case is compelling: lower cost per claim, reduced aging AR, and improved net revenue yield.
But even with these advantages, AI cannot replace the human element.
Where Humans Still Win: The Nuance of Denials
While algorithms excel at pattern recognition and automation, denials management is rarely one-dimensional. Each payer has unique rules, each denial reason carries context, and many disputes require nuanced clinical or contractual interpretation.
Seasoned denial specialists bring several advantages that machines can’t replicate:
- Clinical and Coding Judgment: Determining whether a procedure met medical necessity criteria or whether documentation supports a DRG assignment requires clinical and regulatory insight that no algorithm can fully automate.
- Appeal Writing and Negotiation: Effective appeals often depend on narrative, tone, and payer-specific precedent. All elements that rely on experience, not just data.
- Cross-Functional Collaboration: Denials often stem from upstream issues in scheduling, clinical documentation, or coding. Human analysts connect the dots, facilitating corrective action across departments.
- Relationship Management: Hospitals that foster strong payer relationships can often resolve denials faster through direct communication, which is a task that requires diplomacy and trust, not code.
In short, AI can tell you what happened and why, but humans determine what to do about it.
The Hybrid Model: Best of Both Worlds
The most effective revenue cycle organizations no longer ask, “AI or human?” They design workflows where each complements the other.
A successful hybrid denial-management model follows a structured, three-phase approach:
- AI-Driven Triage and Prioritization
AI systems scan incoming denials, categorize them by type and payer, and assign a probability of overturn. This allows hospital RCM teams to allocate human expertise where it matters most, on high-value, complex, or clinical denials.
Example: If AI detects a trend of “CO-197” (authorization required), it can auto-route those cases for pre-authorization validation or generate appeal templates while humans focus on clinical denials involving “CO-50” (medical necessity). - Human-Led Resolution and Escalation
Analysts handle appeals, complex payer disputes, and systemic root-cause analysis. They also refine the AI model by flagging miscategorized denials or incorrect predictions, creating a continuous learning feedback loop. - Analytics and Continuous Improvement
By merging human feedback with machine learning insights, RCM leaders gain a unified view of performance which include denial rates, overturn percentages, appeal success by payer, and FTE productivity.
This data empowers CFOs to make evidence-based decisions about staffing, vendor partnerships, and technology investments.
The result: a cycle of faster recovery, fewer denials, and smarter resource allocation.
What CFOs and Revenue Cycle Leaders Should Measure
The strategic question is not whether AI or humans should manage denials. It’s how to measure success once both are in play. Leading health systems are tracking the following KPIs to evaluate hybrid effectiveness:
- Denial Prevention Rate: Percentage of claims corrected before submission due to AI insights.
- Appeal Win Rate: Success percentage of human-authored appeals versus automated submissions.
- Days to Resolution: Average time from initial denial to final payment or adjustment.
- Cost per Denial Worked: Total labor and technology cost divided by recovered dollars.
- AI Accuracy Rate: Percentage of AI categorizations or predictions verified as correct by human review.
- Root Cause Recurrence: Frequency of repeated denials post-correction.
Hospitals that adopt these metrics often find that AI amplifies the productivity of their human workforce, enabling a smaller, more specialized team to handle higher volumes with better accuracy.
The Human ROI: Retaining Talent and Expertise
CFOs know that labor costs are the largest line item in the revenue cycle. But automation isn’t just about cost reduction, it’s also about talent optimization.
When staff are freed from repetitive data entry or tracking tasks, they can focus on higher-value functions:
- Root-cause elimination
- Payer contract review
- Clinical documentation improvement
- Denial prevention initiatives
Moreover, hospitals that position AI as a support tool rather than a replacement report higher employee satisfaction and lower turnover. In an industry where burnout and attrition are endemic, that benefit carries real financial weight.
Risk Considerations for Leaders
AI deployment in RCM is not without risk. CFOs and compliance leaders should consider:
- Data Integrity: AI outputs are only as good as the data fed into them. Poor data quality or incomplete remittances can lead to inaccurate predictions.
- Regulatory Oversight: Automated denial handling must still comply with payer contracts, CMS guidelines, and HIPAA.
- Transparency and Trust: Clinicians and staff must understand why AI makes certain recommendations as black-box algorithms can erode confidence.
- Over-Automation Pitfalls: Too much reliance on AI can cause missed nuances, particularly for payer appeals where the narrative matters.
Strategic governance, robust audit trails, and clear human-in-the-loop checkpoints are essential for safe, compliant implementation.
The Future of Denials Management
Looking ahead, the most progressive hospitals are moving from denial recovery to denial prevention. AI will increasingly be used to flag risk at the point of scheduling or pre-authorization, ensuring documentation and eligibility are correct before the claim ever leaves the system.
At the same time, human experts will evolve into revenue intelligence analysts by interpreting data, negotiating payer policies, and leading systemic improvements across the revenue cycle continuum.
The end goal is not simply to fix denials faster, but to create a self-learning revenue ecosystem that continuously reduces errors, improves payer collaboration, and enhances patient financial experience.
The Bottom Line
AI is revolutionizing how hospitals manage denials, but it is not a substitute for experience, strategy, or relationships. The most resilient revenue cycle organizations are those that orchestrate AI and human intelligence as partners, not competitors.
For CFOs and revenue cycle leaders, the winning strategy is clear: Automate where you can. Empower where you must. Measure relentlessly. Because in the business of healthcare, the smartest revenue recovery happens when technology accelerates and not replaces human expertise.
About Action RCM Powered by Harris & Harris
At Action RCM, we believe that smarter denial management starts with balance by pairing advanced automation and analytics with the precision, empathy, and judgment of experienced professionals. Our team specializes in denials management, complex claims (MVA, WC, VA/TriWest, COB), and patient balance resolution, supported by proprietary ClaimQuest™ technology that integrates AI insights with human expertise.
Whether your organization needs a partner to reduce avoidable denials, recover aged AR, or optimize revenue cycle workflows, Action RCM delivers measurable results that protect margins and enhance patient trust.
To learn more, visit www.ActionRCM.com or contact info@actionrcm.com.
